INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2013

Curcumin shows potential therapeutic efficacy and safety across multiple chronic diseases based on completed and ongoing clinical trials.

This review evaluates the pharmaceutical uses of curcumin, an active polyphenol found in turmeric. More than 65 human clinical trials including over 1,000 patients have been completed, with as many as 35 clinical trials underway. Preclinical and clinical research indicates curcumin targets multiple signaling pathways and chronic conditions, including cancer, cardiovascular, metabolic, pulmonary, neurological, autoimmune, and liver diseases.

Study type
Narrative review
Who was studied
More than 1,000 patients across over 65 completed human clinical trials
What was measured
Safety and therapeutic efficacy of curcumin in various chronic diseases

THE PAPER

Curcumin, a component of turmeric: from farm to pharmacy.

Gupta SC, Kismali G, Aggarwal BB. Biofactors, 2013.

PubMed 23339055 ↗DOI 10.1002/biof.1079 ↗

Heart & arteriesDiabetes & blood sugarCancerBrain & moodOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.